Joshua Schafer

Joshua Schafer is a declared insider of Zevra Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 14 March 2023 to 3 February 2026, the count stands at 9 filings.

On the open market, the record shows 3 purchases worth €16k and 3 sales worth €186k. Netting one side against the other leaves €170k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

A typical purchase (the median) is worth €5,026. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 4 February 2026 with an open-market sale (€82k) in Zevra Therapeutics, Inc. The most recent open-market purchase was published on 6 September 2023, 1,160 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.